CLINICAL ROLE -
Novel Combination Therapies in Relapsed/ Refractory Classical Hodgkin Lymphoma
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Read More
Recent Clinical Trials Reveal Important Updates in Adjuvant Therapy for Resectable Non–Small Cell Lung Cancer
Integrating immunotherapies will continue to improve patient outcomes and quality of life.